null
ChEBI ID: 26440
| Member | Definition | Role |
|---|---|---|
| 5-Hydroxymethylcytidine | 5-Hydroxymethylcytidine | |
| 5'-oleoyl cytarabine | Elacytarabine | |
| benzoic acid [3,4-dihydroxy-5-(5-methyl-2,4-dioxo-1-pyrimidinyl)-2-oxolanyl]methyl ester | benzoic acid [3,4-dihydroxy-5-(5-methyl-2,4-dioxo-1-pyrimidinyl)-2-oxolanyl]methyl ester | |
| cytarabine | A pyrimidine nucleoside in which cytosine is attached to D-arabinofuranose via a beta-N(1)-glycosidic bond. Used mainly in the treatment of leukaemia, especially acute non-lymphoblastic leukaemia, cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. It also has antiviral and immunosuppressant properties. | cytarabine |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5,660 (38.20) | 18.7374 |
| 1990's | 3,019 (20.38) | 18.2507 |
| 2000's | 2,627 (17.73) | 29.6817 |
| 2010's | 2,646 (17.86) | 24.3611 |
| 2020's | 865 (5.84) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 2,431 (15.66%) | 5.53% |
| Reviews | 1,055 (6.80%) | 6.00% |
| Case Studies | 2,172 (13.99%) | 4.05% |
| Observational | 26 (0.17%) | 0.25% |
| Other | 9,837 (63.38%) | 84.16% |